We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

altona Diagnostics GmbH

altona Diagnostics GmbH develops and commercializes real-time PCR based assays and molecular diagnostic test solution... read more Featured Products: More products

Download Mobile App





Altona Diagnostics Exhibits AltoStar Product Range at ECCMID 2022

By LabMedica International staff writers
Posted on 22 Apr 2022
Print article
Image: AltoStar Automation System AM16 robotic pipetting workstation (Photo courtesy of altona Diagnostics)
Image: AltoStar Automation System AM16 robotic pipetting workstation (Photo courtesy of altona Diagnostics)

Altona Diagnostics GmbH (Hamburg, Germany) exhibited its AltoStar product line of automated real-time PCR testing solutions suitable for high-throughput laboratories at ECCMID 2022. The event brought together the best and brightest in the field of clinical microbiology and infectious diseases from all over the world.

The flexible and efficient AltoStar Molecular Diagnostic Workflow automates your PCR analyses from sample extraction to PCR results and enables full traceability. At ECCMID 2022, altona demonstrated the AltoStar Automation System AM16, a pipetting workstation, in combination with the AltoStar Connect software, is the centerpiece of the AltoStar Workflow. It is intended to be used in combination with the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5 and altona Diagnostics PCR kits for automated purification of nucleic acids and automated assay setup for in vitro diagnostic purposes.

The AltoStar Connect software used to operate the AltoStar Automation System AM16 is a time-saving state-of-the-art application software that provides loading dialogue to guide through each loading step in order to ensure the completeness of the set up procedure. It can be connected to one or several real-time PCR instruments for their automatic programming and allows sample information and worklist to be imported via barcode reader or LIMS. It features predefined purification protocols and offers automated selection of controls and standards.

In addition, altona presented the AltoStar reagents that are altona Diagnostics-specific products, which are part of the workflow based on AltoStar AM16 and AltoStar Connect software. The AltoStar PCR kits are based on real-time PCR technology, utilizing PCR for amplification of specified target sequences and target-specific probes in order to detect amplified DNA or RNA. The AltoStar Purification Kit 1.5 uses magnetic particle technology and is intended to be used for automated isolation and purification of nucleic acids from specified human specimens for in vitro diagnostic purposes. It permits simultaneous purification of RNA and DNA from multiple sample types. The AltoStar Internal Control 1.5 is intended to be used as a nucleic acid extraction, amplification and detection control for in vitro diagnostic purposes. The control contains the internal purification control and is added at the beginning of the purification procedure. All tubes and containers of the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5 and the AltoStar PCR Kit 1.5 are barcoded by the AltoStar system for automated identification, localization and verification of lot conformity, as well as non-expiry.

Related Links:
altona Diagnostics GmbH 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Anti-Annexin V IgG/IgM Assay
Anti-Annexin V IgG/IgM ELISA
New
Automated Pipetting System
apricot DC1

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.